An overview of our integrated CDMO and CRO capabilities for biologics—from cell line development to commercial manufacturing and tech transfer support.
When choosing the right biologics development and manufacturing partner, the ability to scale with your program is key. At Thermo Fisher Scientific, our end-to-end, integrated CDMO and CRO capabilities for biologics provide support at every stage of the drug development journey—from concept to commercialization—so you can benefit from flexible, tailored support from a single partner.
This brochure outlines our full suite of services and solutions for biologics development and manufacturing, including cell line development, upstream and downstream process development, analytical and formulation development, process characterization and validation, clinical and commercial manufacturing, and technical transfer support.
It also explores our Path to IND for biologics program, which enables simultaneous IND/IMPD submission and initiation of Phase I clinical trials—with funding included—and delivers a ready-to-use drug product in as few as nine months.